SEC Form D filing

Optimvia, LLC, 2026-04-08

An SEC Form D private-offering notice from Cincinnati, OH, a $500,000 filer-stated offering target in Biotech. Filed 2026-04-08. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Optimvia, LLC site↗ Verified via SEC Form D

Biopharmaceutical company using its ADEPT enzyme engineering platform to manufacture biosynthetic heparin without animal sourcing.

Filed 2026-04-08Filed to raise $500,000First money in 2026-03-26Raised so far $75,000HQ (as filed) Cincinnati, OHSector Biotech web-verified against the company’s own siteStage (inferred) Pre-seedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified optimvia.com↗Named in the filing 4 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source